Inventor · disambiguated record
Isabelle Coste-Invernizzi
Also filed as: COSTE-INVERNIZZI ISABELLE
3 granted patents·6 pending applications·0 citations·filing 2005–2022
42Inventor score
Files withCENTRE LEON BERARD3LEBECQUE SERGE3COSTE-INVERNIZZI ISABELLE1SCHERING CORP1UNIV CLAUDE BERNARD LYON1
Top patents by PatentIndex Score
9 records- 0159US12509465B2Benzoimidazole derivatives as anticancer agentsCENTRE LEON BERARD·Filed 2022·Granted Dec 30, 2025·0 cites·17 claims
- 0249US2025235458A1Benzimidazole derivatives for use in the treatment or prevention of a histiocytosis or a craniopharyngiomaUNIV CLAUDE BERNARD LYON·Filed 2022·Application pending·0 cites
- 0349US2012045523A1Combination of a tlr3 ligand and a chemotherapy agent which acts on the intrinsic "apoptosis" pathway in the treatment of cancerLEBECQUE SERGE·Filed 2009·Application pending·0 cites
- 0446US11384081B2Benzoimidazole derivatives as anticancer agentsCENTRE LEON BERARD·Filed 2017·Granted Jul 12, 2022·0 cites·15 claims
- 0545US2009285779A1Induction of apoptosis in toll-like receptor expressing tumor cellsLEBECQUE SERGE·Filed 2007·Application pending·0 cites
- 0643US2006147456A1Induction of apoptosis in toll-like receptor expressing tumor cellsLEBECQUE SERGE·Filed 2005·Application pending·0 cites
- 0734US9683986B2Treatment of cancer by inhibition of the MYD88/ERK MAP kinase interactionCENTRE LEON BERARD·Filed 2012·Granted Jun 20, 2017·0 cites·10 claims
- 0833US2006259989A1Sporadic tumor mouse model for drug discoverySCHERING CORP·Filed 2006·Application pending·0 cites
- 0928US2006141490A1MyD88 as a therapeutic target for cancerCOSTE-INVERNIZZI ISABELLE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Isabelle Coste-Invernizzi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →